NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Analytical Comparison of Methods for Extraction of Short Cell-Free DNA from Urine.

Author(s): Oreskovic A, Brault ND, Panpradist N, Lai JJ, Lutz BR

Publication: J Mol Diagn, 2019, Vol. 21, Page 1067-1078

PubMed ID: 31442674 PubMed Review Paper? No

Purpose of Paper

This study investigated the effect of extraction kit on recovery of different size fragments of DNA from urine, of low concentration spiked in DNA and on PCR inhibition.

Conclusion of Paper

The hybridization capture method recovered >75% of the spiked-in synthetic DNA of each fragment size, but the other kits were not able to effectively recover DNA fragments of at least one size. Detection of low concentration (10 copies/mL) spiked-in 40 nt fragment DNA in urine occurred in all specimens extracted using hybridization capture, Q Sepharose, and Norgen, but the signal was weaker in specimens extracted using Norgen. PCR inhibitory effects of cell-free DNA (cfDNA) extracted from urine using hybridization capture, the Wizard/guanidinium thiocyanate (GuSCN) method, Q Sepharose, and QIAamp were observed only when the reaction contained 40% isolated urine DNA, but inhibition was observed starting at 20% MagMAX isolated DNA and regardless of concentration when DNA was isolated using Norgen.

Studies

  1. Study Purpose

    This study investigated the effect of extraction kits on recovery of different size fragments of DNA from urine, recovery of low concentration spiked-in DNA, and effects on PCR inhibition. The effect of pH, salt concentration, and urine DNA concentration on the recovery of spiked in DNA from buffer using each kit was also examined. Urine from five healthy volunteers were pooled, preserved with 10 mmol/L EDTA, and stored at -80°C. DNA was extracted from urine using Q Sepharose anion exchange resin, Norgen Urine Cell-free Circulating DNA Purification Mini Kit, QIAamp Circulating Nucleic Acid Kit, MagMAX Cell-free DNA Isolation Kit, after mixing with guanidinium thiocyanate using Wizard Minipreps DNA Purification Resin, or by hybridization capture. Different size regions (25, 40, 80, and 150 bp) of IS6110 were quantified by real-time PCR and inhibitory effects were investigated by adding in varying amounts of cfDNA extracted from urine.

    Summary of Findings:

    While the hybridization capture method recovered >75% of the spiked-in synthetic DNA of each fragment size, the Norgen Kit recovered 72% of the 25 nt fragment but less than 50% of all other fragments, the Q Sepharose method recovered 63-75% of the 40-150 nt fragments but only 9% of the 25 nt fragment, the MagMAX Kit recovered 66% of the 150 nt fragment but <50% of all other fragments, and the Wizard/GuSCN and QIAamp Kit recovered <20% of the DNA of each size. Further,  PCR was positive (at least one replicate) for all urine specimens spiked with low concentrations (10 copies/mL) of the 40 nt fragment when DNA was isolated with hybridization capture, Q sepharose, or Norgen, but the signal was weaker in specimens extracted using Norgen and specimens were PCR positive in every reaction only when DNA was isolated by hybridization capture. Further investigation using buffer instead of urine found that while most of the methods were robust to pH, salt concentration, and urine DNA concentration, recovery of DNA using the Wizard/GuSCN method decreased as pH increased above 6 and improved with higher background DNA concentrations. Importantly, cfDNA extracted from urine using hybridization capture, Wizard/GuSCN, Q Sepharose, and QIAamp showed no inhibitory effect on PCR when the reaction contained <40% extracted cfDNA, but cfDNA extracted using MagMAX showed PCR inhibition when the reaction contained ≥20% extracted DNA and cfDNA extracted using Norgen had an inhibitory effect on PCR regardless of the amount added.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    DNA Real-time qPCR
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components Biospecimen components 10 copies/mL spiked in DNA
    100,000 copies/mL spiked in DNA
    Real-time qPCR Specific Length of gene fragment 25 nt
    40 nt
    80 nt
    150 nt
    Analyte Extraction and Purification Analyte isolation method Wizard resin/guanidinium thiocyanate
    Q Sepharose
    Norgen
    QIAamp
    MagMAX

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...